Although CD8+ T cells are increased [173], they might not be sufficient to eliminate EBV-infected cells in EBV-associated DLBCL because fewer central and effector memory CD8+ T cells are found among patients with EBV-positive DLBCL [174]. The gene discussed is CD8A; the disease is diffuse large B-cell lymphoma.